SAN

78.76

+0.57%↑

SHL.DE

41.6

+1.17%↑

ORNBV.FI

69.6

+1.61%↑

QDEL

24.04

+4.34%↑

ACB

3.55

-1.11%↓

SAN

78.76

+0.57%↑

SHL.DE

41.6

+1.17%↑

ORNBV.FI

69.6

+1.61%↑

QDEL

24.04

+4.34%↑

ACB

3.55

-1.11%↓

SAN

78.76

+0.57%↑

SHL.DE

41.6

+1.17%↑

ORNBV.FI

69.6

+1.61%↑

QDEL

24.04

+4.34%↑

ACB

3.55

-1.11%↓

SAN

78.76

+0.57%↑

SHL.DE

41.6

+1.17%↑

ORNBV.FI

69.6

+1.61%↑

QDEL

24.04

+4.34%↑

ACB

3.55

-1.11%↓

SAN

78.76

+0.57%↑

SHL.DE

41.6

+1.17%↑

ORNBV.FI

69.6

+1.61%↑

QDEL

24.04

+4.34%↑

ACB

3.55

-1.11%↓

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Open

SectorHealthcare

85.9 -2.83

Buy Sell

Overview

Share price change

24h

Current

Min

85.4

Max

88.6

Key metrics
By Trading Economics
Income	25M
Sales	258M
P/E Sector Avg	17.275 110.024
Dividend yield	0.98
Profit margin	9.734
Employees	2,497
EBITDA	48M

Dividends
By Dow Jones
Dividend yield Sector Avg	0.98% 2.26%
Next Earnings	27 mar 2026

Market Stats
By TradingEconomics
Market Cap	1B
Previous open	88.73
Previous close	85.9

News Sentiment

By Acuity

50%

165 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

72.6 / 75.1 Support & Resistance

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 lut 2026, 22:31 UTC

Earnings

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 lut 2026, 22:18 UTC

Earnings

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 lut 2026, 22:11 UTC

Earnings

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 lut 2026, 21:52 UTC

Earnings

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 lut 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 lut 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 lut 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 lut 2026, 23:34 UTC

Market Talk

Earnings

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 lut 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 lut 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 lut 2026, 22:45 UTC

Earnings

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 lut 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 lut 2026, 22:37 UTC

Earnings

Nutrien 4Q EPS $1.18 >NTR.T

18 lut 2026, 22:37 UTC

Earnings

Nutrien 4Q Sales $5.34B >NTR.T

18 lut 2026, 22:35 UTC

Earnings

Pan American Silver 4Q EPS $1.07 >PAAS

18 lut 2026, 22:35 UTC

Earnings

Pan American Silver 4Q Rev $1.18B >PAAS

18 lut 2026, 22:30 UTC

Earnings

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 lut 2026, 22:29 UTC

Earnings

Kinross Gold 4Q EPS 75c >K.T

18 lut 2026, 22:22 UTC

Earnings

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 lut 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 lut 2026, 22:16 UTC

Earnings

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 lut 2026, 22:05 UTC

Earnings

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 lut 2026, 22:03 UTC

Earnings

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 lut 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 lut 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q Sales $929M >KALU

18 lut 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 lut 2026, 22:00 UTC

Earnings

Kinross Gold 4Q Adj EPS 67c >KGC

18 lut 2026, 22:00 UTC

Earnings

Kinross Gold 4Q Sales $2.02B >KGC

18 lut 2026, 21:56 UTC

Earnings

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 lut 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

Vetoquinol SA Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Technical Score

By Trading Central

72.6 / 75.1Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

165 / 351 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.